Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aqu Alu

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|December 31, 2024
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trialsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|February 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariantsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|November 20, 2024
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variantsHong Lei, Weiqi Hong, Jingyun Yang, et al.
Nature Communications|September 17, 2022
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantCai He, Jingyun Yang, Weiqi Hong, et al.
The Journal of Clinical Investigation|September 17, 2024
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like proteaseWenyan Ren, Weiqi Hong, Jingyun Yang, et al.
Medcomm|April 29, 2024
A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variantsWeiqi Hong, Hong Lei, Dandan Peng, et al.
Cellular & Molecular Immunology|March 11, 2022
Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cellsWeiqi Hong, Jingyun Yang, Jun Zou, et al.
Nature Biomedical Engineering|September 22, 2025
Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variantWeiqi Hong, Ping Cheng, Jingyun Yang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|December 31, 2024
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trialsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|February 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariantsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|November 20, 2024
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variantsHong Lei, Weiqi Hong, Jingyun Yang, et al.
Nature Communications|September 17, 2022
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantCai He, Jingyun Yang, Weiqi Hong, et al.
The Journal of Clinical Investigation|September 17, 2024
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like proteaseWenyan Ren, Weiqi Hong, Jingyun Yang, et al.
Medcomm|April 29, 2024
A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variantsWeiqi Hong, Hong Lei, Dandan Peng, et al.
Cellular & Molecular Immunology|March 11, 2022
Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cellsWeiqi Hong, Jingyun Yang, Jun Zou, et al.
Nature Biomedical Engineering|September 22, 2025
Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variantWeiqi Hong, Ping Cheng, Jingyun Yang, et al.
Pageof 4